MedTrace Logo

Microembolic Detection in Acute Ischemic Stroke Patients With Atrial Fibrillation and Outcome

NCT06018090 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2023-08-30

No results posted yet for this study

Summary

This multicenter international prospective cohort study will include patients with AIS with a known or newly diagnosed anticoagulant-naïve AF. All centers will use the same transcranial Doppler machine for one-hour monitoring with bilateral 2-MHz probes within 24 hours of symptom onset. Recordings will be analyzed for MES by a blinded central reader. The primary aim is to determine the proportion of patients with MES and the association of MES with functional outcomes assessed by a modified Rankin scale (mRS) score at 90 days.

Conditions

Interventions

OTHER

The presence and rate of MES measured by TCD monitoring

TCD monitoring within 24 hours from the last known well time. Bilateral M1 segments of middle cerebral artery were insonated at a single depth with 2-MHz transducers secured by a probe-holder.

Sponsors & Collaborators

  • University of Giessen

    collaborator OTHER

  • University of Padova

    collaborator OTHER

  • University of Ostrava

    collaborator OTHER

  • Clinical Hospital Centre Zagreb

    collaborator OTHER

  • Centro Hospitalar De São João, E.P.E.

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-06
Primary Completion
2022-08-31
Completion
2022-10-06

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06018090 on ClinicalTrials.gov